7 months ago
RXDX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Bottom 9%
#4052 out of 4414 analysts
Average Return
-3.56%
Win Rate
37%43 out of 116
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-12 - 2023-04-18 | Buy |
Prometheus Biosciences IncRXDX | +224.83% | $59.57 | $193.50 | 2022-10-03 - 2023-04-18 | Buy |
Prometheus Biosciences IncRXDX | +222.70% | $33.30 | $107.46 | 2021-12-12 - 2022-12-12 | Buy |
Portola Pharmaceuticals IncPTLA | +160.17% | $6.93 | $18.03 | 2020-04-22 - 2020-07-01 | Buy |
Global Blood Therapeutics IncGBT | +88.37% | $35.35 | $66.59 | 2021-11-04 - 2022-08-09 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cormedix IncCRMD | 2 | Buy | $10.00 | +196.74% | Maintains | 15 days ago |
Viridian Therapeutics IncVRDN | 5 | Buy | $35.00 | +112.38% | Reiterates | 16 days ago |
Viracta Therapeutics IncVIRX | 6 | Buy | $6.00 | +1,112.12% | Maintains | 20 days ago |
Aptose Biosciences IncAPTO | 7 | Buy | $18.00 | +569.14% | Maintains | 20 days ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Buy | $191.00 | +67.16% | Maintains | 21 days ago |
Xencor IncXNCR | 4 | Buy | $32.00 | +74.67% | Maintains | 22 days ago |
Adc Therapeutics SaADCT | 8 | Buy | $6.00 | +679.22% | Maintains | 22 days ago |
Pacira Biosciences IncPCRX | 5 | Buy | $58.00 | +114.66% | Maintains | a month ago |
Alpine Immune Sciences IncALPN | 2 | Buy | $22.00 | +42.21% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 9 | Buy | $33.00 | +49.12% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 5 | Buy | $24.00 | +291.52% | Maintains | a month ago |
Amgen IncAMGN | 7 | Hold | $256.00 | -3.98% | Maintains | a month ago |
Ideaya Biosciences IncIDYA | 5 | Buy | $36.00 | +15.50% | Maintains | a month ago |
Spruce Biosciences IncSPRB | 6 | Buy | $8.00 | +483.94% | Reiterates | 3 months ago |
Verastem IncVSTM | 4 | Buy | $32.00 | +400.00% | Maintains | 4 months ago |
Verrica Pharmaceuticals IncVRCA | 4 | Buy | $14.00 | +258.06% | Maintains | 4 months ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $0.75 | +792.86% | Downgrades | 5 months ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | +0.07% | Reiterates | 6 months ago |
Inovio Pharmaceuticals IncINO | 5 | Hold | $2.00 | +429.10% | Reiterates | 7 months ago |
Atyr Pharma IncLIFE | 4 | Buy | $19.00 | +1,457.38% | Reiterates | 7 months ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | +0.04% | Maintains | 7 months ago |
Nuvation Bio IncNUVB | 3 | Buy | $5.00 | +278.79% | Maintains | 7 months ago |
Morphic Holding IncMORF | 5 | Buy | $80.00 | +231.81% | Maintains | 7 months ago |
Seagen IncSGEN | 5 | Buy | $229.00 | +7.25% | Maintains | 9 months ago |
Exelixis IncEXEL | 1 | Buy | $29.00 | N/A | Maintains | a year ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | a year ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 2 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Gamida Cell LtdGMDA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.